Robuta

https://ualr.edu/donagheyscholars/2020/05/22/donaghey-scholar-katie-zakrzewski-named-ua-little-rocks-2020-whitbeck-award-winner/ Donaghey Scholar Katie Zakrzewski Named UA Little Rock's 2020 Whitbeck Award Winner - Donaghey... Oct 29, 2024 - This year’s president of the Student Government Association not only captured the hearts and minds of the student body of the University of Arkansas at Little... ua little rockaward winnerdonagheyscholarkatie https://www.nasdaq.com/market-activity/stocks/srrk/dividend-history Scholar Rock Holding Corporation Common Stock (SRRK) Dividend History | Nasdaq Stay up-to-date on Scholar Rock Holding Corporation Common Stock (SRRK) Dividends, Current Yield, Historical Dividend Performance, and Payment Schedule. scholar rockcommon stockdividend historyholdingcorporation https://www.stocktitan.net/sec-filings/SRRK/schedule-13g-a-scholar-rock-holding-corp-amended-passive-investment-d-f581d7ec7cf0.html Redmile reports 3.6% stake in Scholar Rock | SRRK SEC Filing - Form SCHEDULE 13G/A Aug 14, 2026 - Redmile Group and Jeremy C. Green report beneficial ownership of 4.31M Scholar Rock shares, or 3.6% of common stock, based on 119.83M shares outstanding. stake inscholar rocksec filingredmilereports https://kttc.marketminute.com/article/bizwire-2026-6-12-scholar-rock-reports-new-employee-inducement-grants-under-nasdaq-listing-rule-5635c4 Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | KTTC Scholar Rock (NASDAQ: SRRK; the “Company”) today announced that the company granted inducement equity awards covering an aggregate of 134,345 shares of its... scholar rockreports newemployeeinducementgrants https://arcadeforge.online/scholar-rock-more-than-just-sma-biotech-with-q2-2025-obesity-treatment-data-nasdaqsrrk/ Scholar Rock: More Than Just SMA Biotech With Q2 2025 Obesity Treatment Data (NASDAQ:SRRK) - Arcade... Jan 30, 2025 - This article was written by scholar rockmore thanobesity treatmentsmabiotech https://scholarrock.com/patients-families/patient-stories/kim/ Kim | Scholar Rock Dec 23, 2024 - shares some of her favorite things about her child, Jilli, a teenager living with SMA. scholar rockkim https://www.samsaracap.com/portfolios/scholar-rock-holding-corp-inc/ Scholar Rock Holding Corp, Inc. – SAMSARA BIOCAPITAL Scholar Rock (SRRK) is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious... scholar rockholdingcorpincsamsara https://www.panabee.com/idea/is-scholar-rock-srrk-a-buy-11142025 Is Scholar Rock (SRRK) a Buy? | Nov 14 2025 Scholar Rock's SMA drug, apitegromab, targets a 2026 launch after a constructive FDA meeting. It could be a first-in-class muscle therapy for a $5B market. Key... scholar rockbuynov https://en.bulios.com/ticker/SRRK/earnings Scholar Rock (SRRK) Earnings - Next Date and History - Bulios When does Scholar Rock report earnings? The next earnings date for SRRK, plus historical results: EPS and revenue vs. estimates. scholar rocknext dateearningshistory https://notreload.xyz/xy/fda-approves-srrk-drug-for-sma-muscle-weakness/ FDA Approves Scholar Rock Drug for SMA Muscle Weakness Sep 14, 2026 - The FDA approved Scholar Rock’s Isembyld, the first SMA therapy aimed at muscle wasting in patients already on nerve-targeted treatment. scholar rockmuscle weaknessfdaapprovesdrug https://scholarrock.com/pp_asset/srk-181/ SRK-181 Archives | Scholar Rock scholar rocksrkarchives